Oncopeptides Chief Financial Officer Henrik Bergentoft takes office today

Stockholm – November 13, 2023 – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult to treat cancers, today announces that Henrik Bergentoft today takes office as the company´s new Chief Financial Officer.

“I am happy to welcome Henrik who with his robust experience and personal qualities will constitute a major asset for Oncopeptides and its leadership,” says Sofia Heigis, CEO of Oncopeptides. “His more than 20 years of experience from leading finance roles at both medical and non-medical listed companies will be beneficial for us as we continue to build an organization designed for growth.”